Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

354 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients.
Maringwa J, Quinten C, King M, Ringash J, Osoba D, Coens C, Martinelli F, Reeve BB, Gotay C, Greimel E, Flechtner H, Cleeland CS, Schmucker-Von Koch J, Weis J, Van Den Bent MJ, Stupp R, Taphoorn MJ, Bottomley A; EORTC PROBE Project and Brain Cancer Group. Maringwa J, et al. Among authors: cleeland cs. Ann Oncol. 2011 Sep;22(9):2107-2112. doi: 10.1093/annonc/mdq726. Epub 2011 Feb 15. Ann Oncol. 2011. PMID: 21324954 Free article. Clinical Trial.
Making better use of existing cancer data: Patient Reported Outcomes and Behavioural Evidence: a new international initiative.
Bottomley A, Quinten C, Coens C, Martinelli F, Mauer M, Maringwa J, Cleeland CS, Flechtner H, Gotay C, Greimel E, King M, Osoba D, Taphoorn MJ, Reeve BB, Ringash J, Schmucker-Von Koch J, Weis J. Bottomley A, et al. Among authors: cleeland cs. Eur J Cancer Care (Engl). 2009 Mar;18(2):105-7. doi: 10.1111/j.1365-2354.2009.01092.x. Eur J Cancer Care (Engl). 2009. PMID: 19267723 No abstract available.
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials.
Maringwa JT, Quinten C, King M, Ringash J, Osoba D, Coens C, Martinelli F, Vercauteren J, Cleeland CS, Flechtner H, Gotay C, Greimel E, Taphoorn MJ, Reeve BB, Koch JS, Weis J, Smit EF, van Meerbeeck JP, Bottomley A; EORTC PROBE project and the Lung Cancer Group. Maringwa JT, et al. Among authors: cleeland cs. Support Care Cancer. 2011 Nov;19(11):1753-60. doi: 10.1007/s00520-010-1016-5. Epub 2010 Oct 1. Support Care Cancer. 2011. PMID: 20886240
Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes.
Sprangers MA, Sloan JA, Barsevick A, Chauhan C, Dueck AC, Raat H, Shi Q, Van Noorden CJ; GENEQOL Consortium. Sprangers MA, et al. Qual Life Res. 2010 Dec;19(10):1395-403. doi: 10.1007/s11136-010-9759-5. Epub 2010 Oct 14. Qual Life Res. 2010. PMID: 20945161 Free PMC article.
Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data.
Martinelli F, Quinten C, Maringwa JT, Coens C, Vercauteren J, Cleeland CS, Flechtner H, Gotay C, Greimel E, King M, Mendoza T, Osoba D, Reeve BB, Ringash J, Koch JS, Shi Q, Taphoorn MJ, Weis J, Bottomley A; European Organisation for Research and Treatment of Cancer Clinical Groups. Martinelli F, et al. Among authors: cleeland cs. Expert Rev Pharmacoecon Outcomes Res. 2011 Oct;11(5):587-99. doi: 10.1586/erp.11.51. Expert Rev Pharmacoecon Outcomes Res. 2011. PMID: 21958103
Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival.
Quinten C, Maringwa J, Gotay CC, Martinelli F, Coens C, Reeve BB, Flechtner H, Greimel E, King M, Osoba D, Cleeland C, Ringash J, Schmucker-Von Koch J, Taphoorn MJ, Weis J, Bottomley A. Quinten C, et al. J Natl Cancer Inst. 2011 Dec 21;103(24):1851-8. doi: 10.1093/jnci/djr485. Epub 2011 Dec 7. J Natl Cancer Inst. 2011. PMID: 22157640 Free PMC article.
Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).
Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, Mendoza TR, Hay J, Atkinson TM, Abernethy AP, Bruner DW, Cleeland CS, Sloan JA, Chilukuri R, Baumgartner P, Denicoff A, St Germain D, O'Mara AM, Chen A, Kelaghan J, Bennett AV, Sit L, Rogak L, Barz A, Paul DB, Schrag D. Basch E, et al. Among authors: cleeland cs. J Natl Cancer Inst. 2014 Sep 29;106(9):dju244. doi: 10.1093/jnci/dju244. Print 2014 Sep. J Natl Cancer Inst. 2014. PMID: 25265940 Free PMC article.
354 results